Claudio Perez Leighton

Dr. Claudio Perez Leighton


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

17 July 2012 in Annals of the New York Academy of Sciences
Verified
Journal Article
Open access
PDF file
CKCatherine M Kotz
Catherine M Kotz
JNJoshua Patrick Nixon
Joshua Patrick Nixon
TBTammy Butterick
Tammy Butterick
CLClaudio Perez Leighton
Claudio Perez Leighton
JTJennifer Teske
Jennifer Teske
CBCharles Billington
Charles Billington
Resistance to obesity is becoming an exception rather than the norm, and understanding mechanisms that lead some to remain lean in spite of an obesigenic environment is critical if we are to find new ways to reverse this trend. Levels of energy intake and physical activity both contribute to body weight management, but it is challenging for most to adopt major long‐term changes in either factor. Physical activity outside of formal exercise, also referred to as activity of daily living, and in stricter form, spontaneous physical activity (SPA), may be an attractive modifiable variable for obesity prevention. In this review, we discuss individual variability in SPA and NEAT (nonexercise thermogenesis, or the energy expended by SPA) and its relationship to obesity resistance. The hypothalamic neuropeptide orexin (hypocretin) may play a key role in regulating SPA and NEAT. We discuss how elevated orexin signaling capacity, in the context of a brain network modulating SPA, may play a major role in defining individual variability in SPA and NEAT. Greater activation of this SPA network leads to a lower propensity for fat mass gain and therefore may be an attractive target for obesity prevention and therapy.

3 November 2017 in Current Obesity Reports
Verified
Journal Article
Closed access
PDF file
CKCatherine M Kotz
Catherine M Kotz
CLClaudio Perez Leighton
Claudio Perez Leighton
JTJennifer A. Teske
Jennifer A. Teske
CBCharles J. Billington
Charles J. Billington

24 January 2011 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
CLClaudio Perez Leighton
Claudio Perez Leighton
TSTiffany M. Schmidt
Tiffany M. Schmidt
JAJoel Abramowitz
Joel Abramowitz
LBLutz Birnbaumer
Lutz Birnbaumer
KPKofuji Paulo
Kofuji Paulo

1 September 2015 in SLEEP
Verified
Journal Article
Closed access
VMVijayakumar Mavanji
Vijayakumar Mavanji
CLClaudio Perez Leighton
Claudio Perez Leighton
CKCatherine M. Kotz
Catherine M. Kotz
CBCharles J. Billington
Charles J. Billington
SPSairam Parthasarathy
Sairam Parthasarathy
JTJennifer A. Teske
Jennifer A. Teske
S and full research articles published in SLEEP, the official journal of the APSS. Sleep and sleep disorder scientific findings.

1 October 2012 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
CLClaudio Perez Leighton
Claudio Perez Leighton
KBKelsey Boland
Kelsey Boland
JTJennifer A. Teske
Jennifer A. Teske
CBCharles Billington
Charles Billington
CKCatherine M. Kotz
Catherine M. Kotz
There is significant variability in diet-induced obesity (DIO) among humans and rodents, which has been associated with differences in intrinsic spontaneous physical activity (SPA). The orexin neuropeptides positively modulate SPA through multiple brain sites, but the effects of DIO on orexin's activity are not well understood. In this study, we tested the hypothesis that DIO sensitivity is mediated by decreased SPA and changes in the function of the orexins. As a DIO model, we used male Sprague-Dawley rats fed a high-fat (HF; 45% kcal from fat) or a low-fat (LF; 10% kcal from fat) diet for 10 wk. We measured SPA before and after HF or LF feeding and expression of orexin receptors by real-time PCR after dietary treatments. We tested DIO effects on orexin signaling by measuring SPA after injection of orexin A in the rostral lateral hypothalamus (RLH) before and after 10 wk of HF feeding. Finally, we tested whether daily orexin A RLH injections prevent DIO caused by HF feeding. Our results show that resistance to DIO is associated with an increase in SPA, SPA after injection of orexin A in RLH, and orexin receptor expression in sites that mediate orexin's effect on SPA, including RLH. We show that daily injections of orexin peptide in RLH prevent DIO without altering food intake. We estimate that the energetic cost of SPA after orexin A RLH injection accounts for approximately 61% of the extra caloric intake associated with HF intake, suggesting additional effects of orexins. In summary, our results suggest that variability in DIO sensitivity is mediated through adaptations in the activity of the orexin peptides and their receptors.